Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  CytoTools AG    T5O   DE000A0KFRJ1

Delayed Quote. Delayed  - 12/02 04:31:57 pm
8.799 EUR   +6.02%
10/25 CYTOTOOLS : announces personnel change
08/30 CYTOTOOLS : DermaTools action for damages
04/27 CYTOTOOLS : DermaTools signs contracts for production by a new Germa..
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
11/28/2016 11/29/2016 11/30/2016 12/01/2016 12/02/2016 Date
7.827(c) 8(c) 8.499(c) 8.299(c) 8.799(c) Last
340 1 485 5 909 2 627 1 373 Volume
-3.36% +2.21% +6.24% -2.35% +6.02% Change
More quotes
Financials (€)
Sales 2015 1,50 M
EBIT 2015 -1,70 M
Net income 2015 -1,70 M
Finance 2015 3,30 M
Yield 2015 -
Sales 2016 2,60 M
EBIT 2016 -1,70 M
Net income 2016 -1,70 M
Finance 2016 2,30 M
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
EV / Sales2015 9,53x
EV / Sales2016 5,88x
Capitalization 17,6 M
More Financials
Company
CytoTools AG operates as a biotechnology company, which engages in developing therapeutic from research on programmed death cell.The company was founded by Dirk Kaiser and Mark-Andre Freyberg in 2000 and is headquartered in Darmstadt, Germany. 
More about the company
Latest news on CYTOTOOLS AG
10/25 CYTOTOOLS : announces personnel change
10/21 DGAP-ADHOC : Die CytoTools AG gibt eine personelle Veränderung im Vorstand bekan..
08/30 CYTOTOOLS : DermaTools action for damages
08/26 DGAP-NEWS : CytoTools AG: Das Tochterunternehmen DermaTools Biotech GmbH reicht ..
07/29 DGAP-NEWS : Wechsel im Aufsichtsrat der CytoTools AG - Herr Dr. Tober legt aus..
05/23 DGAP-NEWS : CytoTools AG: Resultate aus der Phase II/III Studie zur Behandlung d..
04/27 CYTOTOOLS : DermaTools signs contracts for production by a new German manufactur..
04/22 DGAP-NEWS : DermaTools Biotech GmbH identifiziert neuen Hersteller für Wirkstoff..
02/03 CYTOTOOLS : strenghthens DermaTools Biotech GmbH with a  capital increase
02/03 CYTOTOOLS : stärkt das Tochterunternehmen DermaTools Biotech GmbH durch Kapitale..
More news
Sector news : Bio Therapeutic Drugs
12/03DJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
11/30 ACTELION : Rejecting J&J could leave Actelion with 'lot of explaining to do'
11/28 Actelion's ambitious independent-minded CEO will drive up takeover price
11/26DJWHAT'S NEWS : Business & Finance -- WSJ
More sector news : Bio Therapeutic Drugs
Advertisement
Chart CYTOTOOLS AG
Duration : Period :
CytoTools AG Technical Analysis Chart | T5O | DE000A0KFRJ1 | 4-Traders
Full-screen chart
Technical analysis trends CYTOTOOLS AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 11,5 €
Spread / Average Target 31%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mark-Andre Freyberg CEO & Head-Investor Relations
Manfred May Chairman-Supervisory Board
Dirk Kaiser Chief Research Officer
Markus H. Weissbach Chief Medical Officer
Dieter Tober Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CYTOTOOLS AG-19.51%19
AMGEN, INC.-11.25%107 132
GILEAD SCIENCES, INC.-27.17%95 410
CELGENE CORPORATION-1.78%91 187
REGENERON PHARMACEUTIC..-31.34%39 310
ACTELION LTD40.40%21 739
More Results